Clinical Trial Update: Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase II randomized trial compares two versus five fractions of stereotactic ablative radiotherapy for intermediate-risk prostate cancer and is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Prostate CA | Phase 2 | Status: RECRUITING